lunsumio
roche registration gmbh - mosunetuzumab - eitilæxli, follicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
trepulmix
scipharm sàrl - treprostinil járn - háþrýstingur, lungnabólga - blóðþurrðandi lyf - treatment of adult patients with who functional class (fc) iii or iv and:inoperable chronic thromboembolic pulmonary hypertension (cteph), orpersistent or recurrent cteph after surgical treatmentto improve exercise capacity.
creon magasýruþolið hart hylki 35.000
viatris aps - pancreatinum - magasýruþolið hart hylki - 35.000
cyklokapron filmuhúðuð tafla 500 mg
viatris aps - acidum tranexamicum inn - filmuhúðuð tafla - 500 mg